{"transactions":[{"id":863924,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-03-04T21:37:44.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on January 26, 2026, with a grant date of March 2, 2026, and represents the Reporting Person's annual equity award for 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in full on March 2, 2027, subject to the Reporting Person's continued service on the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":5.35,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001397331-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000139733126000002/ownership.xml","form_type":"4"}},{"id":999526,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-14T13:00:03.000Z","date":"2025-11-12","kind":"purchase","planned":false,"acquired":true,"shares":9498,"price":2.1,"value":19945.8,"ownership":{"direct":false,"nature":"RFW3 Revocable Trust"},"balance_after":9864,"source":{"system":"sec-edgar","filing":"0001193125-25-281626","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000119312525281626/ownership.xml","form_type":"4"}},{"id":1187398,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T21:04:49.000Z","date":"2025-03-31","kind":"purchase","planned":false,"acquired":true,"shares":38145,"price":2.1438,"value":81775.251,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.12 to $2.1697, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price in the transaction described in this footnote."}],"balance_after":108982,"source":{"system":"sec-edgar","filing":"0000950170-25-048698","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025048698/ownership.xml","form_type":"4"}},{"id":1187397,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T21:04:49.000Z","date":"2025-03-28","kind":"purchase","planned":false,"acquired":true,"shares":22192,"price":2.27,"value":50375.84,"ownership":{"direct":true},"balance_after":70837,"source":{"system":"sec-edgar","filing":"0000950170-25-048698","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025048698/ownership.xml","form_type":"4"}},{"id":1224987,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-03-05T21:22:14.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025, and represents the Reporting Person's annual equity award for 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests in full on March 3, 2026, subject to the Reporting Person's continued service on the vesting date."}],"balance_after":50000,"derivative":{"exercise_price":2.46,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-033637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017025033637/ownership.xml","form_type":"4"}},{"id":1350295,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T12:05:04.000Z","date":"2024-11-25","kind":"purchase","planned":false,"acquired":true,"shares":2619,"price":3.67,"value":9611.73,"ownership":{"direct":true},"balance_after":430058,"source":{"system":"sec-edgar","filing":"0000950170-24-131251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024131251/ownership.xml","form_type":"4"}},{"id":1350294,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-27T12:05:04.000Z","date":"2024-11-25","kind":"purchase","planned":false,"acquired":true,"shares":3647,"price":3.6199,"value":13201.7753,"ownership":{"direct":true},"balance_after":427439,"source":{"system":"sec-edgar","filing":"0000950170-24-131251","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024131251/ownership.xml","form_type":"4"}},{"id":1471500,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-06-24T20:19:03.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall fully vest on the first anniversary after the Grant Date (06/20/2024), subject to a continued service relationship."}],"balance_after":23000,"derivative":{"exercise_price":10.65,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000950170-24-076736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024076736/ownership.xml","form_type":"4"}},{"id":1496008,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:01:03.000Z","date":"2024-05-31","kind":"purchase","planned":false,"acquired":true,"shares":55000,"price":1.38,"value":75900.0,"ownership":{"direct":true},"balance_after":423792,"source":{"system":"sec-edgar","filing":"0000950170-24-067945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024067945/ownership.xml","form_type":"4"}},{"id":1498623,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:05:03.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":18656,"price":1.34,"value":24999.04,"ownership":{"direct":true},"balance_after":368792,"source":{"system":"sec-edgar","filing":"0000950170-24-066557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024066557/ownership.xml","form_type":"4"}},{"id":1498622,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:05:03.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":11375,"price":1.32,"value":15015.0,"ownership":{"direct":true},"balance_after":350136,"source":{"system":"sec-edgar","filing":"0000950170-24-066557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000095017024066557/ownership.xml","form_type":"4"}},{"id":1664572,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-01T21:53:13.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":0.7,"value":2450.0,"ownership":{"direct":true},"balance_after":338761,"source":{"system":"sec-edgar","filing":"0001437749-24-002837","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002837/rdgdoc.xml","form_type":"4"}},{"id":1664571,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-01T21:53:13.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":42879,"price":0.72,"value":30872.88,"ownership":{"direct":true},"balance_after":335261,"source":{"system":"sec-edgar","filing":"0001437749-24-002837","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002837/rdgdoc.xml","form_type":"4"}},{"id":1664570,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-01T21:53:13.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":57121,"price":0.71,"value":40555.91,"ownership":{"direct":true},"balance_after":292382,"source":{"system":"sec-edgar","filing":"0001437749-24-002837","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002837/rdgdoc.xml","form_type":"4"}},{"id":1664569,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-01T21:53:13.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":5127,"price":0.71,"value":3640.17,"ownership":{"direct":true},"balance_after":235261,"source":{"system":"sec-edgar","filing":"0001437749-24-002837","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002837/rdgdoc.xml","form_type":"4"}},{"id":1664568,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-01T21:53:13.000Z","date":"2024-01-30","kind":"purchase","planned":false,"acquired":true,"shares":18579,"price":0.71,"value":13191.09,"ownership":{"direct":true},"balance_after":230134,"source":{"system":"sec-edgar","filing":"0001437749-24-002837","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002837/rdgdoc.xml","form_type":"4"}},{"id":1667448,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-30T21:57:17.000Z","date":"2024-01-29","kind":"purchase","planned":false,"acquired":true,"shares":21235,"price":0.64,"value":13590.4,"ownership":{"direct":true},"balance_after":211555,"source":{"system":"sec-edgar","filing":"0001437749-24-002571","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002571/rdgdoc.xml","form_type":"4"}},{"id":1667447,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-30T21:57:17.000Z","date":"2024-01-29","kind":"purchase","planned":false,"acquired":true,"shares":4031,"price":0.64,"value":2579.84,"ownership":{"direct":true},"balance_after":190320,"source":{"system":"sec-edgar","filing":"0001437749-24-002571","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002571/rdgdoc.xml","form_type":"4"}},{"id":1667446,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-30T21:57:17.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":0.54,"value":27000.0,"ownership":{"direct":true},"balance_after":186289,"source":{"system":"sec-edgar","filing":"0001437749-24-002571","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002571/rdgdoc.xml","form_type":"4"}},{"id":1667445,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-30T21:57:17.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.55,"value":13750.0,"ownership":{"direct":true},"balance_after":136289,"source":{"system":"sec-edgar","filing":"0001437749-24-002571","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002571/rdgdoc.xml","form_type":"4"}},{"id":1667444,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-30T21:57:17.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":8513,"price":0.59,"value":5022.67,"ownership":{"direct":true},"balance_after":111289,"source":{"system":"sec-edgar","filing":"0001437749-24-002571","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002571/rdgdoc.xml","form_type":"4"}},{"id":1667443,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-30T21:57:17.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":14850,"price":0.61,"value":9058.5,"ownership":{"direct":true},"balance_after":102776,"source":{"system":"sec-edgar","filing":"0001437749-24-002571","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002571/rdgdoc.xml","form_type":"4"}},{"id":1667442,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-30T21:57:17.000Z","date":"2024-01-26","kind":"purchase","planned":false,"acquired":true,"shares":12250,"price":0.61,"value":7472.5,"ownership":{"direct":true},"balance_after":87926,"source":{"system":"sec-edgar","filing":"0001437749-24-002571","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002571/rdgdoc.xml","form_type":"4"}},{"id":1670308,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-26T22:38:52.000Z","date":"2024-01-25","kind":"purchase","planned":false,"acquired":true,"shares":22134,"price":0.49,"value":10845.66,"ownership":{"direct":true},"balance_after":75676,"source":{"system":"sec-edgar","filing":"0001437749-24-002322","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002322/rdgdoc.xml","form_type":"4"}},{"id":1670307,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-26T22:38:52.000Z","date":"2024-01-24","kind":"purchase","planned":false,"acquired":true,"shares":29862,"price":0.49,"value":14632.38,"ownership":{"direct":true},"balance_after":53542,"source":{"system":"sec-edgar","filing":"0001437749-24-002322","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774924002322/rdgdoc.xml","form_type":"4"}},{"id":1700503,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-26T22:00:27.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":3663,"price":0.3283,"value":1202.5629,"ownership":{"direct":false,"nature":"By RFW3 Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.3249 to $0.3300, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":3663,"source":{"system":"sec-edgar","filing":"0001437749-23-035321","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923035321/rdgdoc.xml","form_type":"4"}},{"id":1706178,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-20T00:10:42.000Z","date":"2023-12-19","kind":"purchase","planned":false,"acquired":true,"shares":13680,"price":0.32,"value":4377.6,"ownership":{"direct":true},"balance_after":23680,"source":{"system":"sec-edgar","filing":"0001437749-23-034933","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034933/rdgdoc.xml","form_type":"4"}},{"id":1706177,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-20T00:10:42.000Z","date":"2023-12-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.26,"value":2600.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001437749-23-034933","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034933/rdgdoc.xml","form_type":"4"}},{"id":1711784,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-12-14T23:32:06.000Z","date":"2023-12-12","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% vests 12/12/2024."}],"balance_after":930000,"derivative":{"exercise_price":0.24,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001437749-23-034473","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923034473/rdgdoc.xml","form_type":"4"}},{"id":1949025,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-03-17T21:10:31.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% vests 2/21/2024."}],"balance_after":700000,"derivative":{"exercise_price":0.38,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001437749-23-007085","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923007085/rdgdoc.xml","form_type":"4"}},{"id":1949024,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":63029,"kind":"person","name":"Williamson Robert F III","position":1,"cik":"0001397331","reported_name":"Williamson Robert F III","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2023-03-17T21:10:31.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":470000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vest monthly over three years."}],"balance_after":470000,"derivative":{"exercise_price":0.38,"expiration_date":"2033-02-21","underlying":"Common Stock","underlying_shares":470000},"source":{"system":"sec-edgar","filing":"0001437749-23-007085","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774923007085/rdgdoc.xml","form_type":"4"}}]}